Quick Answer
Silence Therapeutics plc reported Total Revenue of $559.0 thousand for fiscal year 2025.
Silence Therapeutics plc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $559.0K | -98.7% |
| 2024 | $43.26M | +36.7% |
| 2023 | $31.64M | +46.1% |
| 2022 | $21.66M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $159.0K | -89.4% | -29.0% |
| June 30, 2025 | $224.0K | -70.4% | +57.7% |
| March 31, 2025 | $142.0K | -99.1% | -90.5% |
| September 30, 2024 | $1.50M | — | +98.1% |
| June 30, 2024 | $756.0K | — | -95.2% |
| March 31, 2024 | $15.70M | — | — |
- Silence Therapeutics plc showed a decrease of -98.7% in Total Revenue compared to the prior fiscal year.
- Over the 2022–2025 period, Silence Therapeutics plc’s total revenue has declined by 97.4% (from $21.66 million to $559.0 thousand).
- The most recent figure is from Silence Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: